These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 10699311)

  • 1. Targeted drug delivery via the folate receptor.
    Sudimack J; Lee RJ
    Adv Drug Deliv Rev; 2000 Mar; 41(2):147-62. PubMed ID: 10699311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting therapeutic and imaging agents to folate receptor positive tumors.
    Reddy JA; Allagadda VM; Leamon CP
    Curr Pharm Biotechnol; 2005 Apr; 6(2):131-50. PubMed ID: 15853692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
    Hilgenbrink AR; Low PS
    J Pharm Sci; 2005 Oct; 94(10):2135-46. PubMed ID: 16136558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-targeted gene delivery via folate-conjugated polyethylenimine.
    Guo W; Lee RL
    AAPS PharmSci; 1999; 1(4):E19. PubMed ID: 11741215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted drug delivery via folate receptors.
    Zhao X; Li H; Lee RJ
    Expert Opin Drug Deliv; 2008 Mar; 5(3):309-19. PubMed ID: 18318652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and properties of folate receptor-targeted cationic liposomes].
    Yan Y; Qi XR
    Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.
    Wang S; Low PS
    J Control Release; 1998 Apr; 53(1-3):39-48. PubMed ID: 9741912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-linked lipid-based nanoparticle for targeted gene delivery.
    Hattori Y; Maitani Y
    Curr Drug Deliv; 2005 Jul; 2(3):243-52. PubMed ID: 16305426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-mediated delivery of macromolecular anticancer therapeutic agents.
    Lu Y; Low PS
    Adv Drug Deliv Rev; 2002 Sep; 54(5):675-93. PubMed ID: 12204598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate receptor-targeted liposomes as vectors for therapeutic agents.
    Gosselin MA; Lee RJ
    Biotechnol Annu Rev; 2002; 8():103-31. PubMed ID: 12436917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy.
    Pan XQ; Wang H; Shukla S; Sekido M; Adams DM; Tjarks W; Barth RF; Lee RJ
    Bioconjug Chem; 2002; 13(3):435-42. PubMed ID: 12009931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
    Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
    Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-targeted non-viral DNA vectors for cancer gene therapy.
    Ward CM
    Curr Opin Mol Ther; 2000 Apr; 2(2):182-7. PubMed ID: 11249640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy.
    Reddy JA; Dean D; Kennedy MD; Low PS
    J Pharm Sci; 1999 Nov; 88(11):1112-8. PubMed ID: 10564057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.
    Kranz DM; Patrick TA; Brigle KE; Spinella MJ; Roy EJ
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9057-61. PubMed ID: 7568072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans.
    Lee D; Lockey R; Mohapatra S
    J Nanosci Nanotechnol; 2006; 6(9-10):2860-6. PubMed ID: 17048492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
    Pan X; Lee RJ
    Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.
    Saul JM; Annapragada A; Natarajan JV; Bellamkonda RV
    J Control Release; 2003 Sep; 92(1-2):49-67. PubMed ID: 14499185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells.
    Atkinson SF; Bettinger T; Seymour LW; Behr JP; Ward CM
    J Biol Chem; 2001 Jul; 276(30):27930-5. PubMed ID: 11359781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.